UB-551

N/A

Report date: 2025/05/07 14:50:44

Base Information

Drug NameUB-551

Drug Alias NameLong acting interferon alpha 8长效干扰素α8Interferon alpha 8 biobetterUB-551

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionInterferon alpha replacements

TargetsInterferon alpha

Therapy Area/IndicationsProstatic NeoplasmsOvarian NeoplasmsColorectal Neoplasms +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUbi Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesUbi Pharma Inc

Inactive CompaniesN/A

Active IndicationsProstatic NeoplasmsOvarian NeoplasmsColorectal Neoplasms +[7]

Inactive IndicationsN/A

Other Information

ATC CodeN/A